메뉴 건너뛰기




Volumn 31, Issue SUPPL. 3, 2010, Pages

Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: A preliminary report

Author keywords

Cortical lesions; Multiple sclerosis; Natalizumab

Indexed keywords

MONOCLONAL ANTIBODY; NATALIZUMAB;

EID: 84856395734     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-010-0346-x     Document Type: Conference Paper
Times cited : (7)

References (21)
  • 1
    • 33644584352 scopus 로고    scopus 로고
    • AFFIRM investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    • Polman CH, O'Connor PW, Havrdova E et al (2006) AFFIRM investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Eng J Med 354:899-910
    • (2006) N Eng J Med , vol.354 , pp. 899-910
    • Polman, C.H.1    O'Connor, P.W.2    Havrdova, E.3
  • 2
    • 33644608613 scopus 로고    scopus 로고
    • Natalizumab plus interferon b-1a for relapsing multiple sclerosis
    • Rudick RA, Stuart WH, Calabresi PA et al (2006) Natalizumab plus interferon b-1a for relapsing multiple sclerosis. N Engl J Med 354:911-923
    • (2006) N Engl J Med , vol.354 , pp. 911-923
    • Rudick, R.A.1    Stuart, W.H.2    Calabresi, P.A.3
  • 3
    • 60049089535 scopus 로고    scopus 로고
    • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: A retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
    • Havrdova E, Galetta S, Hutchinson M et al (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol 8:254-260
    • (2009) Lancet Neurol , vol.8 , pp. 254-260
    • Havrdova, E.1    Galetta, S.2    Hutchinson, M.3
  • 5
    • 0034842126 scopus 로고    scopus 로고
    • Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
    • DOI 10.1002/ana.1123
    • Peterson JW, Bö L, Mörk S et al (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389-400 (Pubitemid 32848742)
    • (2001) Annals of Neurology , vol.50 , Issue.3 , pp. 389-400
    • Peterson, J.W.1    Bo, L.2    Mork, S.3    Chang, A.4    Trapp, B.D.5
  • 7
    • 20744442122 scopus 로고    scopus 로고
    • Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging
    • DOI 10.1148/radiol.2361040450
    • Geurts JJ, Pouwels PJ, Uitdehaag BM et al (2005) Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236:254-260 (Pubitemid 40853320)
    • (2005) Radiology , vol.236 , Issue.1 , pp. 254-260
    • Geurts, J.J.G.1    Pouwels, P.J.W.2    Uitdehaag, B.M.J.3    Polman, C.H.4    Barkhof, F.5    Castelijns, J.A.6
  • 10
    • 42549167642 scopus 로고    scopus 로고
    • Extensive cortical inflammation is associated with epilepsy in multiple sclerosis
    • Calabrese M, De Stefano N, Atzori M et al (2008) Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 255:581-586
    • (2008) J Neurol , vol.255 , pp. 581-586
    • Calabrese, M.1    De Stefano, N.2    Atzori, M.3
  • 11
    • 58149095079 scopus 로고    scopus 로고
    • Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study
    • Calabrese M, Filippi M, Rovaris M et al (2009) Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 15:36-41
    • (2009) Mult Scler , vol.15 , pp. 36-41
    • Calabrese, M.1    Filippi, M.2    Rovaris, M.3
  • 12
    • 69549126590 scopus 로고    scopus 로고
    • Magnetic resonance evidence of cortical onset of multiple sclerosis
    • Calabrese M, Gallo P (2009) Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 15:933-941
    • (2009) Mult Scler , vol.15 , pp. 933-941
    • Calabrese, M.1    Gallo, P.2
  • 13
    • 65349092772 scopus 로고    scopus 로고
    • Cortical lesions in primary progressive multiple sclerosis: A 2-year longitudinal MR study
    • Calabrese M, Rocca MA, Atzori M et al (2009) Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 72:1330-1336
    • (2009) Neurology , vol.72 , pp. 1330-1336
    • Calabrese, M.1    Rocca, M.A.2    Atzori, M.3
  • 14
    • 70349084196 scopus 로고    scopus 로고
    • Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis
    • Calabrese M, Agosta F, Rinaldi F et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144-1150
    • (2009) Arch Neurol , vol.66 , pp. 1144-1150
    • Calabrese, M.1    Agosta, F.2    Rinaldi, F.3
  • 15
    • 77950534279 scopus 로고    scopus 로고
    • A three-years MRI study of cortical lesions in relapse-onset multiple sclerosis
    • Calabrese M, Rocca MA, Atzori M et al (2010) A three-years MRI study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67(3):376-383
    • (2010) Ann Neurol , vol.67 , Issue.3 , pp. 376-383
    • Calabrese, M.1    Rocca, M.A.2    Atzori, M.3
  • 16
    • 60049090180 scopus 로고    scopus 로고
    • Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
    • Putzki N, Kollia K, Woods S et al (2009) Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. Eur J Neurol 16:424-426
    • (2009) Eur J Neurol , vol.16 , pp. 424-426
    • Putzki, N.1    Kollia, K.2    Woods, S.3
  • 17
    • 74249110981 scopus 로고    scopus 로고
    • Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: Results from a multicenter study in Switzerland
    • Epub 16 Jan 2010
    • Putzki N, Yaldizli O, Bühler R et al (2010) Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland. Eur Neurol 63:101-106 (Epub 16 Jan 2010)
    • (2010) Eur Neurol , vol.63 , pp. 101-106
    • Putzki, N.1    Yaldizli, O.2    Bühler, R.3
  • 18
    • 33947547648 scopus 로고    scopus 로고
    • Extensive cortical remyelination in patients with chronic multiple sclerosis
    • DOI 10.1111/j.1750-3639.2006.00043.x
    • Albert M, Antel J, Bruck W et al (2007) Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 17:129-138 (Pubitemid 46466131)
    • (2007) Brain Pathology , vol.17 , Issue.2 , pp. 129-138
    • Albert, M.1    Antel, J.2    Bruck, W.3    Stadelmann, C.4
  • 20
    • 0042123685 scopus 로고    scopus 로고
    • Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
    • DOI 10.1191/1352458503ms917oa
    • Bø L, Vedeler CA, Nyland H et al (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9:323-331 (Pubitemid 36958014)
    • (2003) Multiple Sclerosis , vol.9 , Issue.4 , pp. 323-331
    • Bo, L.1    Vedeler, C.A.2    Nyland, H.3    Trapp, B.D.4    Mork, S.J.5
  • 21
    • 0026506799 scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin
    • Yednock TA, Cannon C, Fritz LC et al (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63-66
    • (1992) Nature , vol.356 , pp. 63-66
    • Yednock, T.A.1    Cannon, C.2    Fritz, L.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.